PKD2 and breast carcinoma: In this context, the higher PKD3 levels during breast cancer progression compared with PKD2 and the near absence of PKD1 expression suggest that PKD3 activity may be independent of the expression of the other isoforms, which would support the idea of an autonomously functioning oncogene.